How RhoGDI binds Rho

Citation
K. Longenecker et al., How RhoGDI binds Rho, ACT CRYST D, 55, 1999, pp. 1503-1515
Citations number
58
Categorie Soggetti
Chemistry & Analysis
Journal title
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
ISSN journal
09074449 → ACNP
Volume
55
Year of publication
1999
Part
9
Pages
1503 - 1515
Database
ISI
SICI code
0907-4449(199909)55:<1503:HRBR>2.0.ZU;2-#
Abstract
Like all Rho (Ras homology) GTPases, RhoA functions as a molecular switch i n cell signaling, alternating between GTP- and GDP-bound states, with its b iologically inactive GDP-bound form maintained as a cytosolic complex with RhoGDI (guanine nucleotide-exchange inhibitor). The crystal structures of R hoA-GDP and of the C-terminal immunoglobulin-like domain of RhoGDI (residue s 67-203) are known, but the mechanism by which the two proteins interact i s not known. The functional human RhoA-RhoGDI complex has been expressed in yeast and crystallized (P6(5)22, unit-cell parameters a = b = 139, c = 253 Angstrom, two complexes in the asymmetric unit). Although diffraction from these crystals extends to 3.5 Angstrom and is highly anisotropic, the expe rimentally phased (MAD plus MIR) electron-density map was adequate to revea l the mutual disposition of the two molecules. The result was validated by molecular-replacement calculations when data were corrected for anisotropy. Furthermore, the N-terminus of RhoGDI (the region involved in inhibition o f nucleotide exchange) can be identified in the electron-density map: it is bound to the switch I and switch II regions of RhoA, occluding an epitope which binds Db1-like nucleotide-exchange factors. The entrance of the hydro phobic pocket of RhoGDI is 25 Angstrom from the last residue in the RhoA mo del, with its C-terminus oriented to accommodate the geranylgeranyl group w ithout conformational change in RhoA.